Lomerizine Hydrochloride
盐酸洛美利嗪
Report date: 2022/05/12 17:20:14
NME
Base Information
Drug NameLomerizine Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1999/03/12
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesPfizer Japan IncNanjing Chang'Ao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A